Dinya utilizes a template-independent, multi-enzyme platform for Exponential Synthesis to directly produce double-stranded DNA. This hierarchical approach bypasses the need for intermediate oligos, enabling the rapid creation of long, complex DNA molecules. The service significantly reduces researcher time spent on DNA design, assembly, and cloning failures.
Funding
Funding not disclosed
Founders
Product
Problem
Researchers face challenges in obtaining custom DNA sequences quickly and affordably, hindering the pace of biological research and development. Traditional DNA synthesis methods can be slow and expensive, particularly for gene-length sequences.
Solution
DINYA DNA offers rapid and cost-effective de novo synthesis of gene-length DNA sequences, leveraging proprietary synthetic biology processes. This technology empowers researchers to efficiently create custom DNA sequences tailored to their specific experimental needs. By accelerating the DNA synthesis process, DINYA DNA enables faster research cycles and quicker advancements in various fields of biology. The company's approach aims to overcome the limitations of conventional DNA synthesis, providing a more accessible and efficient solution for researchers.
Target Audience
The primary target audience includes researchers and organizations in the fields of biology, biotechnology, and pharmaceuticals who require custom DNA sequences for their research and development activities.
Features
- Rapid de novo synthesis of gene-length DNA sequences
- Cost-effective DNA synthesis solutions
- Proprietary synthetic biology processes
- Capability to create custom DNA sequences